Vepsitamab (AMG 199) is a bispecific T-cell engager (BiTE) antibody designed for precise dual targeting of CD3 on T cells and MUC17 on tumor cells. This antibody facilitates the redirection of T cell cytotoxic activity towards MUC17-expressing tumor cells, resulting in targeted tumor cell lysis. Additionally, Vepsitamab promotes T cell activation and proliferation, enhancing anti-tumor immune responses. This product is pivotal for research focused on cancer immunotherapy and the molecular mechanisms of T cell-mediated cytotoxicity.
Vepsitamab (AMG 199) is a bispecific T-cell engager (BiTE) antibody designed for precise dual targeting of CD3 on T cells and MUC17 on tumor cells. This antibody facilitates the redirection of T cell cytotoxic activity towards MUC17-expressing tumor cells, resulting in targeted tumor cell lysis. Additionally, Vepsitamab promotes T cell activation and proliferation, enhancing anti-tumor immune responses. This product is pivotal for research focused on cancer immunotherapy and the molecular mechanisms of T cell-mediated cytotoxicity.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
